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DISCUSSION
Dr James Black (Baltimore, Md). I wished to thank the society
for the privilege of discussing this paper. I congratulate DrDosluoglu
on this important contribution and, of course, applaud his diligence in
providing me with a copy of the manuscript well in advance.
The evaluation of preoperative risk before noncardiac surgery
and interventions aimed towards reducing that risk has an integral
part of the modern practice of all vascular and endovascular sur-
geons. This week, a simple PubMed search of coronary risks and
vascular surgery yielded no less than 7,000 hits. As such, this paper
represents a novel departure from the previous studies that contin-
ually reduced preoperative risks to an unwieldy series of biomark-
ers, clinical markers, noninvasive, and invasive testing with the
sundry scoring systems to lay out the risk assessment in some
digestible way.
Dr Dosluoglu and his colleagues retrospectively reviewed 482
patients who underwent revascularization for disabling claudica-
tion and critical limb ischemia, insightfully, dividing the major
portion of their patients based upon functional status and examin-
ing their outcomes. To further inform the audience, 4 METS is
equivalent to 4 miles per hour of walking and, given our popula-
tion and claudicators, a simple estimate would be 4 MET equiva-
lent activity would be taking out the trash or gardening in their
backyard, according to the CDC [Centers for Disease Control].
The authors foundmany statistical differences between these 2
groups; in a multivariate analysis, coronary artery disease, diabetes,
renal insufficiency, COPD, and critical limb ischemia were ex-
tremely predictive of postoperative mortality in poor outcomes. Of
all the variables, critical limb ischemia clearly resounded through
your paper and carries an odds ratio of 14.7 with pretty tight
confidence intervals to predict one’s patients landing as a IIIB
patient before their operation. So I have three questions regarding
this finding. Firstly, would it be justifiable in your estimation to
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consider any critical limb ischemia patients, as highest risk regard-
less of them lacking other significant comorbidities? Secondly, the
AHA and the American College of Cardiology recognized PAD
[peripheral arterial disease] as cardiac risk-equivalent disease, and
should critical limb ischemia really be the emphasis of that deter-
mination and not just a simple wastebasket diagnosis of PAD? And
lastly, going back to my introduction and the lack of proven
efficacy of any preoperative testing strategy to yield survival benefit,
have any of your IIIBs, to your knowledge, undergone cardiac
catheterization to determine the presence of three-vessel disease or
left main disease; the situation wherein many still believe our
mantra of perioperative beta blockade may not be enough to pull
these patients through a vascular reconstruction? Thanks again for
the privilege of discussing your work.
Dr Hasan H. Dosluoglu: Thanks for the insightful ques-
tions. You are correct in the sense that the critical limb ischemia
was seen in 92% in the IIIB group and less than that in the IIIA
group. However, when we looked only the critical limb ischemia
patients, they still turned out to have different outcomes in IIIA
and IIIB patients. So, obviously this does make a difference in this
subgroup that the critical limb ischemia turned out to be one of the
most significant predictors, but these subclassifications are really
not meant for just critical limb ischemia patients, and we would like
to extent it to other subgroups. We do have critical limb ischemia
patients, say diabetic patients with some ulcer, who by definition
are classified as having critical limb ischemia because of tissue loss.
However, some of them do have very good functional status with
good outcomes. So, it is a very good predictor in this subgroup.
You are correct, but I think we still like to keep the functional status
as the major determinant of IIIA and IIIB.
The second question: We did perioperative cardiac evaluation
as routine pre-op, but we did not specifically look for coronary
angiograms or cardiac tests for the purposes of the study. Does the
VA population have perioperative -blockade? All the risk adjust-
ment is actually emphasized heavily in the VA, and this is pretty
much a very uniformly treated group of patients. We are taking
these METS subclassification from the cardiologists in a way
because this is really in the Eagle’s noncardiac surgery risk assess-
ment, so it is not surprising that the coronary artery disease is the
most significant determinant of the IIIA and IIIB in that way. So it
is vice versa, I guess, the cardiac and peripheral limbs affecting each
other in a way.
Dr Martin Back (Tampa, Fla): Nice presentation and good
data. I am not aware of actually any validation data for functional
status that has been proposed in the ACC/AHA classifications for
risk stratification part of noncardiac surgery, so this is good data. I
am gonna echo what Dr Black mentioned, that I think you need to
separate out that ASA IIIG group and take out the critical limb
ischemia patients and look specifically at whether or not condition-
ing or deconditioning affects this functional status and has a
prognostic effect in these patients.
Dr Dosluoglu. Thank you.
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